High Counts Of Blood Eosinophils And Increased Fractional Exhaled Nitric Oxide May Be Biomarkers Of Exacerbation Risk In Patients With Severe Asthma, Study Indicates
June 08, 2020
Pulmonology Advisor (6/5, Jacobs) reported researchers found in the ARIETTA trial “high counts of blood eosinophils combined with increased fractional exhaled nitric oxide (FeNO) may serve as biomarkers for a risk for exacerbations in patients with severe...